Literature DB >> 6230094

Inhibitors of poly (ADP-ribose) synthesis enhance radiation response by differentially affecting repair of potentially lethal versus sublethal damage.

E Ben-Hur, H Utsumi, M M Elkind.   

Abstract

The effect of nicotinamide and m-aminobenzamide, representative inhibitors of poly(ADP-ribose) synthesis, on the survival of V79 Chinese hamster cells following ionizing radiation was studied in plateau- and log-phase cultures. In plateau-phase, after an acute dose of X-rays, nicotinamide partially inhibited the repair of potentially lethal damage that occurs when the plating of such cells is delayed. The incompleteness of the inhibition was attributed to the slowness of the uptake of nicotinamide by unfed plateau-phase cells. Postirradiation incubation of log-phase cells with either of these inhibitors caused a pronounced enhancement of the radiation response which was reflected mainly by a reduction of the shoulder on the survival curve. However, the ability of such treated cells to repair sublethal damage was hardly affected as demonstrated by the reappearance of the shouldered survival curve during a fractionation interval. NAD levels in irradiated cells were rapidly reduced. This reduction was somewhat slower in a radiation sensitive mutant and was almost completely blocked in the presence of m-aminobenzamide. Another treatment that enhances the radiation response, i.e., incubation in D2O medium, facilitated the rate of NAD depletion in irradiated cells. We conclude that inhibitors of poly(ADP-ribose) synthesis inhibit the repair of potentially lethal damage in plateau-phase as well as in log-phase cells with little if any effect on the repair of sublethal damage. Poly(ADP-ribose) appears, therefore, to have a role in the repair of radiation damage that is potentially lethal in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230094      PMCID: PMC2149179     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  9 in total

1.  An improved cycling assay for nicotinamide adenine dinucleotide.

Authors:  C Bernofsky; M Swan
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

2.  Potentially lethal damage versus sublethal damage: independent repair processes in actively growing Chinese hamster cells.

Authors:  H Utsumi; M M Elkind
Journal:  Radiat Res       Date:  1979-02       Impact factor: 2.841

3.  Repair of potentially lethal lesions in x-irradiated, density-inhibited Chinese hamster cells: metabolic effects and hypoxia.

Authors:  G M Hahn; M A Bagshaw; R G Evans; L F Gordon
Journal:  Radiat Res       Date:  1973-08       Impact factor: 2.841

4.  Potentiation of cell killing by inhibitors of poly(ADP-ribose) polymerase in four rodent cell lines exposed to N-methyl-N-nitrosourea or UV light.

Authors:  L G Durrant; J M Boyle
Journal:  Chem Biol Interact       Date:  1982-02       Impact factor: 5.192

5.  Potentially lethal and DNA radiation damage: similarities in inhibition of repair by medium containing D2O and by hypertonic buffer.

Authors:  E Ben-Hur; H Utsumi; M M Elkind
Journal:  Radiat Res       Date:  1980-10       Impact factor: 2.841

6.  Inhibitors of poly-(adenosine diphosphoribose) synthesis slow the resealing rate of x-ray-induced DNA strand breaks.

Authors:  L A Zwelling; D Kerrigan; Y Pommier
Journal:  Biochem Biophys Res Commun       Date:  1982-02-11       Impact factor: 3.575

7.  Deuterium oxide enhancement of Chinese hamster cell response to gamma radiation.

Authors:  E Ben-Hur; E Riklis
Journal:  Radiat Res       Date:  1980-02       Impact factor: 2.841

8.  The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase.

Authors:  N Nduka; C J Skidmore; S Shall
Journal:  Eur J Biochem       Date:  1980-04

9.  (ADP-ribose)n participates in DNA excision repair.

Authors:  B W Durkacz; O Omidiji; D A Gray; S Shall
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

  9 in total
  8 in total

Review 1.  Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options.

Authors:  Svenja Nölting; Ashley Grossman; Karel Pacak
Journal:  Exp Clin Endocrinol Diabetes       Date:  2018-09-20       Impact factor: 2.949

Review 2.  Emerging Role of PARP Inhibitors in Metastatic Prostate Cancer.

Authors:  Serhan Unlu; Joseph W Kim
Journal:  Curr Oncol Rep       Date:  2022-08-06       Impact factor: 5.945

3.  Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma.

Authors:  Ying Pang; Yanxin Lu; Veronika Caisova; Yang Liu; Petra Bullova; Thanh-Truc Huynh; Yiqiang Zhou; Di Yu; Zdenek Frysak; Igor Hartmann; David Taïeb; Karel Pacak; Chunzhang Yang
Journal:  Clin Cancer Res       Date:  2018-04-10       Impact factor: 12.531

4.  Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft.

Authors:  Joana M Senra; Brian A Telfer; Kim E Cherry; Cian M McCrudden; David G Hirst; Mark J O'Connor; Stephen R Wedge; Ian J Stratford
Journal:  Mol Cancer Ther       Date:  2011-08-08       Impact factor: 6.261

5.  Therapies targeting the signal pathways of pheochromocytoma and paraganglioma.

Authors:  Yalin Liu; Longfei Liu; Feizhou Zhu
Journal:  Onco Targets Ther       Date:  2019-09-04       Impact factor: 4.147

6.  Extracellular Nicotinamide Phosphoribosyltransferase Is a Component of the Senescence-Associated Secretory Phenotype.

Authors:  Chisaka Kuehnemann; Kang-Quan Hu; Kayla Butera; Sandip K Patel; Joanna Bons; Birgit Schilling; Cristina Aguayo-Mazzucato; Christopher D Wiley
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

7.  Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.

Authors:  Gerben R Borst; Ramya Kumareswaran; Hatice Yücel; Seyda Telli; Trevor Do; Trevor McKee; Gaetano Zafarana; Jos Jonkers; Marcel Verheij; Mark J O'Connor; Sven Rottenberg; Robert G Bristow
Journal:  Oncotarget       Date:  2017-09-15

Review 8.  ATM-Deficient Cancers Provide New Opportunities for Precision Oncology.

Authors:  Nicholas R Jette; Mehul Kumar; Suraj Radhamani; Greydon Arthur; Siddhartha Goutam; Steven Yip; Michael Kolinsky; Gareth J Williams; Pinaki Bose; Susan P Lees-Miller
Journal:  Cancers (Basel)       Date:  2020-03-14       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.